{
  "ticker": "MYX",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02962591",
  "id": "02962591",
  "pages": 5,
  "price_sensitive": false,
  "date": "20250626",
  "time": "1802",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250626/pdf/06l4t6mmpk3dfc.pdf",
  "summary": "### **Notice of Initial Substantial Holder**  \n**Company:** Mayne Pharma Group Ltd  \n\n#### **Material Information:**  \n- **Substantial Holder:** First Sentier Investors Holdings Pty Limited (indirectly owned by Mitsubishi UFJ Financial Group, Inc. (MUFG)).  \n- **Total Holding:** 4,105,099 fully paid ordinary shares (**5.05% voting power**).  \n  - Breakdown:  \n    - **1,010,146** shares directly held by First Sentier Investors entities.  \n    - **3,094,953** shares under MUFG\u2019s voting power (via investment mandates).  \n- **Relevant Interests:**  \n  - Includes **27,631 shares borrowed** under prime brokerage agreements (subject to recall).  \n- **Consideration Paid:** Disclosed for recent acquisitions (cash amounts for specific parcels in Annexure B).  \n\n#### **Key Takeaway:**  \nNew substantial holder (First Sentier/MUFG) with **5.05% stake**, indicating institutional accumulation. No immediate trading impact noted.",
  "usage": {
    "prompt_tokens": 3451,
    "completion_tokens": 221,
    "total_tokens": 3672,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-26T08:16:26.974822"
}